RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CORMIO G
Collezione ASL Biella

Items : 6

Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study. in Gynecologic oncology / Gynecol Oncol. 2023 Aug;175:182-189. doi: 10.1016/j.ygyno.2023.05.065. Epub 2023 Jun 22.

2023
ASL Biella
AO Ordine Mauriziano

Pignata S; Tomao F; Valabrega G; Zavallone L; Tasca G; Salutari V; Scandurra G; Savarese A; Sambataro D; Petrella MC; Ricciardi GRR; Ronzino G; Naglieri E; Mangili G; Mammoliti S; Lissoni A; De Angelis C; Legge F; Cormio G; Cecere SC; Ceccherini R; Landoni F; Lorusso D; Sabbatini R; Artioli G; Berardi R; Colombo N; Gadducci A;

45TiP A randomized, molecular driven phase II trial of carboplatin-paclitaxel-bev vs carboplatin-paclitaxel-bev-rucaparib vs carboplatin-paclitaxel-rucaparib, selected according to HRD status, in patients with advanced ovarian cancer in Annals of Oncology

2022
ASL Biella

Carbone MV; Giudice E; Camarda F; Nero C; Tronconi F; Lorusso D; Ghizzoni V; Ricci C; Mosconi AM; Cormio G; Valabrega G; Zavallone L; Pignata S; Siena S; Scambia G; Salutari V; Musacchio L;

MITO 25.1: A RANDOMIZED, MOLECULAR DRIVEN PHASE II TRIAL OF CARBOPLATIN-PACLITAXELBEVACIZUMAB VS CARBOPLATIN-PACLITAXELBEVACIZUMAB- RUCAPARIB VS CARBOPLATINPACLITAXEL- RUCAPARIB, SELECTED ACCORDING TO HRD STATUS, IN PATIENTS WITH ADVANCED OVARIAN CANCER in International Journal of Gynecological Cancer

2022
ASL Città di Torino
ASL Biella

Musacchio L; Salutari V; Pignata S; Valabrega G; Zavallone L; Cormio G; Mosconi AM; Giolitto S; Camarda F; Ricci C; Zamagni C; Nero C; Carbone MV; Ghizzoni V; Sorio R; Salvatore S; Tronconi F; Savarese A; Scambia G; Lorusso D;

MITO 25.1: A RANDOMIZED, MOLECULAR DRIVEN PHASE II TRIAL OF CARBOPLATINPACLITAXEL- BEVACIZUMAB VS CARBOPLATIN-PACLITAXEL-BEVACIZUMABRUCAPARIB VS CARBOPLATIN-PACLITAXELRUCAPARIB, SELECTED ACCORDING TO HRD STATUS, IN PATIENTS WITH ADVANCED (STAGE III B-C-IV) OVARIAN, PRIMARY PERITONEAL AND FALLOPIAN TUBE CANCER in International Journal of Gynecological Cancer

2022
ASL Città di Torino
ASL Biella

Musacchio L; Salutari V; Pignata S; Valabrega G; Zavallone L; Cormio G; Mosconi AM; Giolitto S; Giudice E; Ricci C; Zamagni C; Nero C; Carbone MV; Ghizzoni V; Sorio R; Siena S; Tronconi F; Savarese A; Scambia G; Lorusso D;

Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study. in Scientific reports / Sci Rep. 2020 Oct 23;10(1):18190. doi: 10.1038/s41598-020-75316-x.

2020
ASL Biella

Giorda G; Pigozzi E; Loizzi V; Franzese E; Gallà V; Attademo L; Zavallone L; Orditura M; Bologna A; Casanova C; Cormio G; Pignata S; Longo L; Bergamini A; Greco F; Scarpi E; Farolfi A; Giardina D; Cioffi R; De Giorgi U;

Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24). in Targeted oncology / Target Oncol. 2018 Aug;13(4):469-479. doi: 10.1007/s11523-018-0574-1.

2018
ASL Biella

Cioffi R; Pigozzi E; Giardina D; Loizzi V; Franzese E; Zavallone L; Ventriglia J; Bologna A; Orditura M; Cormio G; Longo L; Casanova C; Greco F; Gallà V; Scarpi E; Petrone M; Farolfi A; Pignata S; Giorda G; De Giorgi U;